These GWAS studies have made possible the comparison of the characteristics of certain protein gene expression polymorphisms where they have been assigned a statistical cutoff to be considered predisposing to the disease, such as the PRKCE, BCL2, and TYK2 genes, in the case of MS. The gene discussed is BCL2; the disease is myeloid sarcoma.